BRTX
Price
$1.70
Change
-$0.10 (-5.56%)
Updated
Apr 4 closing price
Capitalization
11.76M
44 days until earnings call
IMRX
Price
$1.41
Change
-$0.10 (-6.62%)
Updated
Apr 4 closing price
Capitalization
50.6M
37 days until earnings call
Ad is loading...

BRTX vs IMRX

Header iconBRTX vs IMRX Comparison
Open Charts BRTX vs IMRXBanner chart's image
BioRestorative Therapies
Price$1.70
Change-$0.10 (-5.56%)
Volume$46.27K
Capitalization11.76M
Immuneering
Price$1.41
Change-$0.10 (-6.62%)
Volume$154.39K
Capitalization50.6M
BRTX vs IMRX Comparison Chart
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. IMRX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and IMRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (BRTX: $1.70 vs. IMRX: $1.41)
Brand notoriety: BRTX and IMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 10% vs. IMRX: 68%
Market capitalization -- BRTX: $11.76M vs. IMRX: $50.6M
BRTX [@Biotechnology] is valued at $11.76M. IMRX’s [@Biotechnology] market capitalization is $50.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 0 FA rating(s) are green whileIMRX’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 0 green, 5 red.
  • IMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, BRTX is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 4 TA indicator(s) are bullish while IMRX’s TA Score has 5 bullish TA indicator(s).

  • BRTX’s TA Score: 4 bullish, 6 bearish.
  • IMRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than BRTX.

Price Growth

BRTX (@Biotechnology) experienced а -6.07% price change this week, while IMRX (@Biotechnology) price change was -14.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

BRTX is expected to report earnings on Aug 19, 2025.

IMRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($50.6M) has a higher market cap than BRTX($11.8M). BRTX YTD gains are higher at: 18.888 vs. IMRX (-35.909). BRTX has higher annual earnings (EBITDA): -11.9M vs. IMRX (-61.43M). IMRX has more cash in the bank: 50.7M vs. BRTX (13.1M). BRTX has less debt than IMRX: BRTX (42.4K) vs IMRX (4.24M). BRTX has higher revenues than IMRX: BRTX (377K) vs IMRX (0).
BRTXIMRXBRTX / IMRX
Capitalization11.8M50.6M23%
EBITDA-11.9M-61.43M19%
Gain YTD18.888-35.909-53%
P/E RatioN/AN/A-
Revenue377K0-
Total Cash13.1M50.7M26%
Total Debt42.4K4.24M1%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXIMRX
RSI
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
88%
Bullish Trend 21 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GP0.460.02
+5.07%
GreenPower Motor Company
AAL9.46-0.05
-0.47%
American Airlines Group
AXGN16.22-0.82
-4.81%
Axogen
PANW153.57-11.60
-7.02%
Palo Alto Networks Inc
ZIM12.52-0.97
-7.19%
ZIM Integrated Shipping Services Ltd

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-5.55%
TCRT - BRTX
33%
Loosely correlated
-30.09%
URGN - BRTX
31%
Poorly correlated
-2.66%
ETNB - BRTX
30%
Poorly correlated
-15.89%
CERO - BRTX
29%
Poorly correlated
+2.30%
IMRX - BRTX
28%
Poorly correlated
-6.62%
More

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-6.62%
SPRB - IMRX
52%
Loosely correlated
-4.13%
NUVL - IMRX
40%
Loosely correlated
-3.78%
VRDN - IMRX
30%
Poorly correlated
-5.22%
INSM - IMRX
30%
Poorly correlated
-5.66%
DNLI - IMRX
29%
Poorly correlated
-7.90%
More